Projects
Research grants and awards held in the PNT Lab, from European consortia to translational seed funding.
Current projects
EUzymat – Eutectozymes as innovative antioxidant materials for biomedical applications
European Commission, Marie Skłodowska-Curie Actions Staff Exchanges (HORIZON-MSCA-2026-SE-01)
A four-year international staff-exchange programme developing eutectic-solvent-based enzyme-mimicking (eutectozyme) antioxidant materials for biomedical use.
Evaluating therapeutic response in adult and paediatric brain cancers using patient-derived 3D tumour models
Industrial Biotechnology Innovation Catalyst (IBIC)
Extends the lab's nanomedicine platform into patient-derived paediatric brain-tumour models.
MyExoFat – Patient-derived micro-fragmented adipose tissue (MFAT) exosomes as drug delivery vehicles for glioblastoma
Confidence for Translation (C4T) Award, Translation Manchester / MRC
Translational development of adipose-tissue-derived exosomes as carriers for localised glioblastoma therapy.
In-situ forming peptide-based subcutaneous solid depot for long-term delivery of cancer drugs
Industrial Biotechnology Innovation Catalyst (IBIC)
The lab leads the in vitro assessment of the developed long-acting depots.
Alginate-based hydrogels for complex 3D scaffolds with biochemical, mechanical and physiological relevance
UoM EPSRC Postdoctoral Pathway Fellowship 2025/26 (Fellow: Dr Rebekah Kay)
An externally funded, independent early-career fellowship hosted in the PNT Lab.
HALo – EPSRC National Hub for Advanced Long-Acting Therapeutics (Healthcare Technologies theme)
EPSRC
The lab leads the development and characterisation of in vitro fluidic models for long-acting therapeutics.
Previous projects
Cell membrane-derived nanoparticles delivering nucleic acids for pre-eclampsia
Manchester–Melbourne–Toronto Research Fund (UoM)
A three-continent collaboration that delivered a placenta-on-a-chip model.
CD200-engineered microglial nanoparticles encapsulating IKK-16 for glioblastoma therapy
Nuttall Funding Award, Geoffrey Jefferson Brain Research Centre (UoM)
Established testing of the lab's nanotherapeutics on human patient tissue with the Division of Neuroscience.
Upcycling fat tissue for localised glioblastoma treatment
Drug Discovery & Advanced Therapeutics Innovation Lab Award, Wellcome Trust & NIHR via Translation Manchester
Seed project that generated the preliminary data behind the MyExoFat C4T award.
Reprogramming glioblastoma’s microenvironment using bio-membrane engineered nano-modulators
Royal Society Research Grant
The lab's first externally peer-reviewed award as an independent group; equipped the core of the laboratory.
Earlier awards & fellowships
Seal of Excellence
European Commission
Awarded to a highly rated proposal submitted to a Horizon Europe call.
